NO124095B - - Google Patents

Download PDF

Info

Publication number
NO124095B
NO124095B NO165897A NO16589766A NO124095B NO 124095 B NO124095 B NO 124095B NO 165897 A NO165897 A NO 165897A NO 16589766 A NO16589766 A NO 16589766A NO 124095 B NO124095 B NO 124095B
Authority
NO
Norway
Prior art keywords
tartar
hydroxy
ethane
ehdp
agents
Prior art date
Application number
NO165897A
Other languages
Norwegian (no)
Inventor
Cune H Mc
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO124095B publication Critical patent/NO124095B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • C02F5/10Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
    • C02F5/14Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances containing phosphorus

Description

Munnpleiemidler for hemning av kalksten. Oral care agents for inhibition of calculus.

Nærværende oppfinnelse vedrorer munnpleiemidler som hemmer dan-nelse av tannsten. The present invention relates to oral care products which inhibit the formation of tartar.

Uttrykket "munnpleiemiddel" som her anvendt, angir et produkt som under den vanlige bruk blir tilbake i munnhulen i en tid tilstrekkelig til å komme i kontakt med i det vesentlige alle tannoverflater. Slike produkter er f.eks. tannpleiemidler, munnvannmidier, tabletter eller pastiller, og opplosninger for lokal anvendelse. The term "mouth care agent" as used here denotes a product which, during normal use, remains in the oral cavity for a time sufficient to come into contact with essentially all tooth surfaces. Such products are e.g. dentifrices, mouthwashes, tablets or lozenges, and solutions for local application.

Tannsten er en avsetning som danner seg på overflatene av tennene ved den gingivale grense. Supragingival tannsten viser seg hovedsakelig i områdene nær åpningene for salivakanalene, f.eks. på de linjuale overflater av de nedre fortenner og på de mot kinnet vendte overflater for forste og annen seksårsjeksler,• Tartar is a deposit that forms on the surfaces of the teeth at the gingival border. Supragingival calculus mainly appears in the areas near the openings for the salivary ducts, e.g. on the linear surfaces of the lower incisors and on the cheek-facing surfaces of the first and second molars,•

og på de bakre overflater av de bakerste jeksler.and on the posterior surfaces of the posterior molars.

Tannsten består av en uorganisk andel som stort sett er kalsiumfosfat anordnet i ethydroksyapatit krystallgitterstruktur lig-nende ben, emalje og dentin. En organisk andel er også til stede og består av avskallede epitelceller, leukocytter, mat-rester og forskjellige arter mikroorganismer. Tartar consists of an inorganic part which is mostly calcium phosphate arranged in a hydroxyapatite crystal lattice structure similar to bone, enamel and dentin. An organic part is also present and consists of desquamated epithelial cells, leukocytes, food residues and different species of microorganisms.

Ved utvikling av tannsten dannes en begynnende avsetning som stort sett er amorft kalsiumfosfat som fastlagt ved rontgen-analyse. Etter som tannsten utvikler seg ved en krystallveksts-fase blir den synlig hvit eller gulaktig i farge, med mindre flekker eller misfarget av et eller annet middel. Foruten å være synlig og uonsket fra et etisk standpunkt er tannstensav-setning en stadig kilde til irritasjon av tannkjottet og videre til gingivitis og andre sykdommer på tennenes bærende deler, During the development of tartar, an initial deposit is formed which is mostly amorphous calcium phosphate as determined by X-ray analysis. As calculus develops through a crystal growth phase, it becomes visibly white or yellowish in color, with minor staining or discolouration by some agent. Apart from being visible and undesirable from an ethical point of view, tartar deposition is a constant source of irritation to the gums and further to gingivitis and other diseases of the supporting parts of the teeth,

og irritasjon nedsetter vevenes motstandsevne overfor endogene og eksogene organismer. and irritation reduces the tissue's resistance to endogenous and exogenous organisms.

En rekke kjemiske og biologiske midler har vært foreslått forA number of chemical and biological agents have been proposed for

å hemme tannstensdannelse eller fjerne tannsten etter at den er dannet. Periodisk fjerning av tannsten ved tannlegen er selv-følgelig en rutinebehandling hos tannlegen. to inhibit tartar formation or remove tartar after it has formed. Periodic removal of tartar by the dentist is, of course, routine treatment at the dentist.

Det har generelt vært foreslått å hemme tannstensdannelse kjemisk ved chelering av kalsium som hindrer kalsiumfosfat-tannstens-prekursor i å danne og/eller nedbryte dannet tannsten ved å fjerne kalsium. En rekke cheleringsmidler, slik som etylen-diamin-tetraeddiksyre, nitrilotrieddiksyre og visse lactoner av sukkersyrer, har vært anvendt for dette formål. Imidlertid begrenser tannstens kjemiske likhet med tannstrukturen brukbar-heten av cheleringsmidler, da de mer effektive cheleringsmidler alvorlig kan skade tannstrukturen ved avkalkning, som det vises av Grossman, "Oral Surgery, Oral Medicine and Oran Patho-logy 7, 484 - 487 (1954)" ogDraus og medarb . "Dental It has generally been proposed to inhibit tartar formation chemically by chelating calcium which prevents calcium phosphate tartar precursor from forming and/or breaking down formed tartar by removing calcium. A number of chelating agents, such as ethylenediaminetetraacetic acid, nitrilotriacetic acid and certain lactones of sugar acids, have been used for this purpose. However, the chemical similarity of tartar to the tooth structure limits the usefulness of chelating agents, as the more effective chelating agents can seriously damage the tooth structure by decalcification, as shown by Grossman, "Oral Surgery, Oral Medicine and Oran Pathology 7, 484-487 (1954) " and Draus et al. "Dental

Progress 3, nr. 2, 79 - 81 (1963)". Således har utviklingenProgress 3, No. 2, 79 - 81 (1963)". Thus has the development

av munnpleiemidler som effektivt hemmer tannsten ved kalsium-chelering vært hemmet av sikkerhetsbetraktninger. of oral care products that effectively inhibit tartar by calcium chelation has been hampered by safety considerations.

Det er nå blitt funnet at etan -1-hydroksy-l,1-difosfonsyre og vannopploselige salter av denne er i besiddelse av overraskende evne til å hemme utvikling av tannsten uten å fjerne kalk fra tannemaljen eller ellers skade tannstrukturen når den anvendes i blandinger som holdes innenfor angitte pH-grenser. It has now been found that ethane-1-hydroxy-1,1-diphosphonic acid and water-soluble salts thereof possess the surprising ability to inhibit the development of calculus without removing lime from the tooth enamel or otherwise damaging the tooth structure when used in mixtures such as kept within specified pH limits.

Nærværende oppfinnelse angår et munnpleiemiddel som her definert, som inneholder fra 0,01 til 10 vekts-% etan-l-hydroksy-1, 1-difosfonsyre eller et vannopploselig salt av denne, fortrinnsvis trinatriumsaltet, idet pH for midlet holdes innen området 5 - 11, fortrinnsvis 7 - 10, og eventuelt slipemiddel som er i det vesentlige fritt for vannopploselig kalsium. The present invention relates to an oral care agent as defined here, which contains from 0.01 to 10% by weight of ethane-1-hydroxy-1,1-diphosphonic acid or a water-soluble salt thereof, preferably the trisodium salt, the pH of the agent being kept within the range 5 - 11, preferably 7 - 10, and any abrasive which is essentially free of water-soluble calcium.

Etan-l-hydroksy-1,1-difosfonsyre har molekular formelEthane-1-hydroxy-1,1-diphosphonic acid has molecular formula

CH^CtOH) (P03H2)2. (Ifolge nomenklatur ved radikaler kan syren også betegnes 1-hydroksyetylidendifosfonsyre). Det letteste krystallbare salt av denne syre oppnås når tre syrehydrogen-atomer erstattes med natrium. Folgelig er et foretrukket salt til bruk i munnpleiemidlet ifolge oppfinnelsen trinatrium-hydrogensalt som har strukturen: CH^CtOH) (PO 3 H 2 ) 2 . (According to the nomenclature for radicals, the acid can also be called 1-hydroxyethylidenediphosphonic acid). The most easily crystallizable salt of this acid is obtained when three acid hydrogen atoms are replaced by sodium. Consequently, a preferred salt for use in the oral care agent according to the invention is trisodium hydrogen salt which has the structure:

Denne forbindelse krystalliserer normalt som heksahydrat som taper noe vann under lufttorring og gir en blanding av heksa-og monohydrat med gjennomsnittlig 3 til 4 molekyler hydrata-sjonsvann. This compound normally crystallizes as hexahydrate which loses some water during air drying and gives a mixture of hexa- and monohydrate with an average of 3 to 4 molecules of water of hydration.

Skjont ethvert alkalimetall, ammonium eller substituert ammon- iumsalt av etan-l-hydroksy-1,1-difosfonsyre kan brukes ved ut-førelsen av oppfinnelsen, er tetranatriumsalt, trinatrium-hydrogensalt, dinatrium-dihydrogensalt, mononatriumtrihydrogen-salt, og blandinger av disse foretrukket. De andre natrium-, kalium-, ammonium- og mono-, di- og trietanolammoniumsalter og blandinger av disse er også egnet. Although any alkali metal, ammonium or substituted ammonium salt of ethane-1-hydroxy-1,1-diphosphonic acid can be used in the practice of the invention, tetrasodium salt, trisodium hydrogen salt, disodium dihydrogen salt, monosodium trihydrogen salt, and mixtures thereof preferred. The other sodium, potassium, ammonium and mono-, di- and triethanol ammonium salts and mixtures thereof are also suitable.

I den folgende beskrivelse betegnes etan-hydroksy-difosfonsyre som EHDP, hvilket uttrykk har til hensikt å angi såvel syreformen som alle de vannopploselige salter av denne. Når formen til EHDP ikke er angitt, betyr % EHDP prosentandelen av trinatrium-hydrogen EHDP og de molare ekvivalenter av den frie syre og andre vannopploselige salter. In the following description, ethane-hydroxy-diphosphonic acid is referred to as EHDP, which term is intended to indicate both the acid form and all the water-soluble salts thereof. When the form of EHDP is not stated, % EHDP means the percentage of trisodium hydrogen EHDP and the molar equivalents of the free acid and other water-soluble salts.

Konsentrasjon av EHDP i munnpleiemidlene etter nærværende oppfinnelse kan være 0,01 % til 10 vektsprosent. Munnpleiemidler som ved den vanlige bruk tilfeldigvis vil svelges i vesentlige mengder, skal inneholde lavere konsentrasjoner av EHDP. Således inneholder et munnvann i overensstemmelse med nærværende oppfinnelse fortrinnsvis mindre enn ca. 3 % og tabletter og tyggegummi mindre enn ca. 1 vekts-% EHDP. Tannpleiemidler og opplosninger for lokal anvendelse, hvor sistnevnte administreres profesjonelt kan inneholde opptil ca. 10 vekts-%, fortrinnsvis fra 0,1 til 5,0 vekts-% EHDP. Concentration of EHDP in the oral care products according to the present invention can be 0.01% to 10% by weight. Oral care products which, during normal use, will accidentally be swallowed in significant quantities, must contain lower concentrations of EHDP. Thus, a mouthwash in accordance with the present invention preferably contains less than approx. 3% and tablets and chewing gum less than approx. 1 wt% EHDP. Dental care products and solutions for local use, where the latter is administered professionally, can contain up to approx. 10% by weight, preferably from 0.1 to 5.0% by weight EHDP.

pH for blandinger etter nærværende oppfinnelse kan være fra 5,0 til 11. Under pH 5,0 kan skade på tannemaljen opptre til tross for det relativt sikre EHDP. Over pH 11,0 oppstår van-skeligheter i å sammensette produkter som har tilfredsstillende smak og mildhet. Et foretrukket pH-område er fra 7,0 til 10. Munnpleiemidlets pH-verdi bestemmer naturligvis omfanget av noytralisasjonen av EHDP. The pH for mixtures according to the present invention can be from 5.0 to 11. Below pH 5.0, damage to the tooth enamel can occur despite the relatively safe EHDP. Above pH 11.0, difficulties arise in putting together products that have a satisfactory taste and mildness. A preferred pH range is from 7.0 to 10. The mouth care agent's pH value naturally determines the extent of the neutralization of EHDP.

Skjont det ikke tilsiktes at nærværende oppfinnelse begrensesAlthough it is not intended that the present invention be limited

av en spesiell teori, er det blitt iakttatt at EHDP forstyrrer utviklingen av tannstendannelse fra amorft kalsiumfosfat gjen-nom krystallvekstfasen til kalsium-hydroksyapanit. Mengder av EHDP som er langt for små til å chelere noen vesentlige mengder av kalsium er blitt funnet å hemme dannelsen av kalsiumhydroksy- of a particular theory, it has been observed that EHDP interferes with the development of tartar formation from amorphous calcium phosphate through the crystal growth phase of calcium hydroxyapanite. Amounts of EHDP that are far too small to chelate any significant amounts of calcium have been found to inhibit the formation of calcium hydroxy-

apatit. Denne selektive virkning på dannelsen av tannstensavsetninger uten avmineralisering på tannemaljen er overraskende. apatite. This selective effect on the formation of tartar deposits without demineralization of the tooth enamel is surprising.

Effektivitet av midlene etter nærværende oppfinnelse i å fore-bygge tannsten ble vist ved Rottetannstensproven som ble utfort som folger: To grupper 20 til 21 dagers gamle rotter av stammenHoltsman-Sprague-Dawley, hvor hver gruppe består av et handyr og et hun-dyr fra hvert av 10 kull, ble anvendt ved denne prove, og den ene gruppe tjener som kontroll- og den annen som provegruppe. Begge dyregrupper ble foret med en tannstensfremkallende diet bestående av 62 % maisstivelse, 32 % ikke fet torrmelk, 2 % leverpulver og 3 % cellulosemel. Lokale anvendelser av en 0,5 % vandig opplosning av trinatrium-hydrogen-etan-l-hydroksy-1, 1-difosfonat justert til pH 10,0 ble anbragt på tennene til hver av dyrene i prbvegruppen to ganger daglig i 3 uker. Lig-nende påforinger av vann ble gjort på hvert dyr i kontrollgrup-pen under eksperimentsperioden. 3 uker etter begynnelsen av proven ble dyrene avlivet og deres jeksler ble gradert med hensyn til tannstensdannelse ved å undersoke områdene og dybden av akkumuleringen på hver av de 44 tannoverflater som ble undersokt i hvert dyr. Gradering ble gjort etter en skala på 0 - 3 for hver overflate. 0 er ingen påviselig kalkavsetning, 3 er dekning av vesentlig 100 % av overflaten med en tykk avsetning og de mellomliggende verdier respresenterer graderinger mellom disse grenser. Den totale tannstensberegning for hvert dyr ble bestemt ved å addere grade-ringene for hver av de 44 overflater. Effectiveness of the agents according to the present invention in preventing calculus was shown by the Rat Tartar Test which was carried out as follows: Two groups of 20 to 21 day old rats of the strain Holtsman-Sprague-Dawley, each group consisting of a male animal and a female animal from each of 10 litters was used in this trial, and one group serves as a control and the other as a test group. Both animal groups were fed a calculus-inducing diet consisting of 62% corn starch, 32% non-fat dry milk, 2% liver powder and 3% cellulose flour. Topical applications of a 0.5% aqueous solution of trisodium hydrogen ethane-1-hydroxy-1,1-diphosphonate adjusted to pH 10.0 were placed on the teeth of each of the animals in the test group twice daily for 3 weeks. Similar applications of water were made to each animal in the control group during the experimental period. 3 weeks after the start of the test, the animals were sacrificed and their molars were graded for calculus formation by examining the areas and depth of accumulation on each of the 44 tooth surfaces examined in each animal. Grading was done on a scale of 0 - 3 for each surface. 0 is no detectable lime deposit, 3 is coverage of essentially 100% of the surface with a thick deposit and the intermediate values represent gradations between these limits. The total calculus count for each animal was determined by adding the grade rings for each of the 44 surfaces.

Resultatene som oppnås i to eksperimenter er angitt i tabellen nedenfor. The results obtained in two experiments are given in the table below.

Det kan sees at vesentlige reduksjoner i tannstensdannelse oppnås med lokalt påforte munnpleiemidler ifolge nærværende oppfinnelse. It can be seen that significant reductions in tartar formation are achieved with locally applied oral care agents according to the present invention.

Sikkerheten for EHDP for anvendelse i kontakt med tannoverflåt-ene ble bestemt ved en kontinuerlig neddykningsprove som ut-fores som folger: Naturlige menneskelige tenner ble neddykket i vandige oppløsninger som inneholder 3 % EHDP ved pH 7,0 og pH 10. Hver fjerde time ble tennene undersokt på avkalkning. The safety of EHDP for use in contact with tooth surfaces was determined by a continuous immersion test performed as follows: Natural human teeth were immersed in aqueous solutions containing 3% EHDP at pH 7.0 and pH 10. Every four hours, teeth examined for decalcification.

I synlig lys kan emaljeavkalkning oppdages ved tap av glans, hvite opake punkter eller svake ruheter i overflatene. Tennene ble undersokt makroskopisk og mikroskopisk ved utlopet av 7 dager. Ingen avkalkning ble iakttatt under denne periode, som angir at disse blandinger forårsaker ingen skade på tannemaljen. In visible light, enamel decalcification can be detected by loss of gloss, white opaque points or slight roughness in the surfaces. The teeth were examined macroscopically and microscopically at the end of 7 days. No decalcification was observed during this period, indicating that these mixtures cause no damage to tooth enamel.

Et tannpleiemiddel, særlig tannpasta som inneholder EHDP er en foretrukket utforelsesform for nærværende oppfinnelse. Tann-pastablandinger inneholder vanligvis slipende materialer, skum-mende midler, bindemidler, fuktemidler, smak- og sotningsmidler. A dentifrice, particularly toothpaste containing EHDP is a preferred embodiment of the present invention. Toothpaste mixtures usually contain abrasive materials, foaming agents, binding agents, wetting agents, flavoring and sooting agents.

Slipematerialene og andre hjelpemidler som anvendes i tannpleiemidler ifolge nærværende oppfinnelse er fortrinnsvis i det vesentlig fri for opploselig kalsium, slik at den sekvesterende eller krystallveksthemmende evne for EHDP ikke reduseres i slik grad at dens anti-tannstensvirkning svekkes. Således brukes vanlige slipemidler som dikalsium-ortofosfat og kalsiumkarbonat fortrinnsvis ikke. Imidlertid kan overveiende p -fase kalsium-pyrofosfat som fremstilles i overensstemmelse med US-patent The abrasive materials and other auxiliaries used in dental care products according to the present invention are preferably essentially free of soluble calcium, so that the sequestering or crystal growth-inhibiting ability of EHDP is not reduced to such an extent that its anti-tartar effect is weakened. Thus, common abrasives such as dicalcium orthophosphate and calcium carbonate are preferably not used. However, predominantly p-phase calcium pyrophosphate which is prepared in accordance with US Pat

nr. 3.112.247, hvilket inneholder relativt lite opploselig kalsium, anvendes. En spesiell foretrukket klasse av slipemidler for anvendelse her er de partikkelformede termoherdende polyme-riserte harpikser, som er beskrevet i US-patent nr. 3.070.510. Egnede harpikser omfatter melaminer, fenolharpikser, urea, melamin-urea, kryss-bundne epoksyder og kryss-bundne polyestere. No. 3,112,247, which contains relatively little soluble calcium, is used. A particularly preferred class of abrasives for use herein are the particulate thermosetting polymerized resins described in US Patent No. 3,070,510. Suitable resins include melamines, phenolic resins, urea, melamine-urea, cross-linked epoxies and cross-linked polyesters.

Andre egnede slipemidler omfatter aluminiumoksyd og de uopplø-selige ikke-kalsium-metafosfater, slik som natrium-metafosfat. Blandinger av slipemidler kan også brukes. I hvert tilfelle kan den totale mengde av slipemidler i tannpleiemidler etter nærværende oppfinnelse være fra 0,5 til 95 vekts-% av tannpleiemidlet.. Fortrinnsvis inneholder tannpasta fra 20 til 60 vekts-% slipemiddel. Slipemiddelpartikkelstorrelsen er fortrinnsvis fra 2 - 20 (j . Other suitable abrasives include aluminum oxide and the insoluble non-calcium metaphosphates, such as sodium metaphosphate. Mixtures of abrasives can also be used. In each case, the total amount of abrasives in dental care products according to the present invention can be from 0.5 to 95% by weight of the dental care product. Preferably, toothpaste contains from 20 to 60% by weight of abrasives. The abrasive particle size is preferably from 2 - 20 (j .

Egnede skummemidler er de som er rimelig stabile og danner skum over et utstrakt pH-område, fortrinnsvis anioniske organiske syntetiske rensemidler. Eksempler på slike midler er vannopploselige salter av alkylsulfat som har fra 10 til 18 karbonatomer i alkylradikalet, slik som natriumlaurylsulfat, vannopploselige salter av sulfonerte monoglycerider av fettsyrer med 10 til 18 karbonatomer, slik som natrium-monoglyceridsul-fonat, salter av C-^Q - C^g fettsyreamider av taurin, slik som natrium-N-mety 1-N-palmitoy 1-taurid, salter av - C-^g fett-syreestere av isetionsyre, og i det vesentlige mette-de ali-fatiske acylamider av mettede monoaminokarboksylsyrer med fra 2 til 6 karbonatomer og i hvilke acylradikalet inneholder 12 Suitable foaming agents are those which are reasonably stable and form foam over a wide pH range, preferably anionic organic synthetic cleaning agents. Examples of such agents are water-soluble salts of alkyl sulfate having from 10 to 18 carbon atoms in the alkyl radical, such as sodium lauryl sulfate, water-soluble salts of sulfonated monoglycerides of fatty acids with 10 to 18 carbon atoms, such as sodium monoglyceride sulfonate, salts of C-^Q - C^g fatty acid amides of taurine, such as sodium-N-methyl 1-N-palmitoy 1-tauride, salts of - C-^g fatty acid esters of isethionic acid, and essentially saturated aliphatic acylamides of saturated monoaminocarboxylic acids with from 2 to 6 carbon atoms and in which the acyl radical contains 12

til 16 karbonatomer, slik som natrium-N-lauroylsarcosid. Blandinger av to eller flere skummemidler kan brukes. to 16 carbon atoms, such as sodium N-lauroyl sarcoside. Mixtures of two or more foaming agents can be used.

Skummemidlet kan være til stede i tannpleiemidlene ettet nærværende oppfinnelse i en mengde fra 0,5 til 5 vekts-% av det totale middel. The foaming agent can be present in the dentifrices according to the present invention in an amount from 0.5 to 5% by weight of the total agent.

Ved fremstilling av tannpasta er det nodvendig å tilsette et fortykningsmateriale for å gi en onsket konsistens. Foretrukne fortykningsmidler er hydroksyetylcellulose og vannopploselige salter av celluloseetere, slik som natrium-karboksymety1-cellu-lose og natrium-karboksymety1-hydroksy-etyl-cellulose. Naturlige gummier, slik som karayagummi, arabisk gummi og tragacant-gummi kan også brukes.Kolloidalt magnesium-aluminiumsilikat eller, finfordelt silica kan brukes som del av fortykningsmidler i en mengde på fra 0,5 til 5,0 vekts-% av den totale blanding kan brukes. When making toothpaste, it is necessary to add a thickening material to give the desired consistency. Preferred thickeners are hydroxyethyl cellulose and water-soluble salts of cellulose ethers, such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxyethyl cellulose. Natural gums, such as gum karaya, gum arabic and gum tragacanth can also be used. Colloidal magnesium aluminum silicate or finely divided silica can be used as part of the thickening agents in an amount of from 0.5 to 5.0% by weight of the total mixture can be used.

Det er også onskelig å inkludere et fuktemiddel i en tannpasta for å forhindre herdning. Egnede fuktemidler omfatter glyserin, It is also desirable to include a humectant in a toothpaste to prevent hardening. Suitable humectants include glycerin,

sorbitol og andre spisbare flerverdige alkoholer. Fukte-sorbitol and other edible polyhydric alcohols. Moisturize

midlet kan utgjore opptil ca 36 vekts-% av tannpastablandingen. the agent can make up to about 36% by weight of the toothpaste mixture.

Egnede smaksmidler omfatter vintergrommolje, peppermynteolje, olje av gronn myrte, sassafrasolje og krydderolje. Sotningsmidler som kan anvendes inkluderer sakkarin, dekstrose, levulose og natriumcyklamat. Suitable flavoring agents include oil of wintergreen, peppermint oil, oil of green myrtle, sassafras oil and clove oil. Blackening agents that can be used include saccharin, dextrose, levulose and sodium cyclamate.

Flere representative munnpleiemidler som illustrerer nærværende oppfinnelse angis i de folgende eksempler. Several representative oral care products that illustrate the present invention are given in the following examples.

EKSEMPEL IEXAMPLE I

En tannpasta med folgende blandinger ble fremstilt ved konven-sjonelle metoder: A toothpaste with the following mixtures was prepared by conventional methods:

Denne blanding hemmer effektivt tannstensdannelse på tannemaljen og når den ble undersokt ved en kontinuerlig neddykningsprove som beskrevet her, ble ingen avkalkning bemerket etter 7 dagers, prove. This composition effectively inhibits calculus formation on tooth enamel and when tested by a continuous immersion test as described herein, no decalcification was noted after the 7 day test.

EKSEMPEL IIEXAMPLE II

En tannpasta ble fremstilt som var identisk i sammensetning til tannpastaen etter eksempel I, borsett fra at 3,0 deler i stedet for 1,5 deler dinatrium-dihydrogen-etan-l-hydroksy-1,1-difosfonat og 30,08 deler i stedet for 31,58 deler vann ble brukt. Denne blanding ble også funnet å være effektiv og forårsaket ingen skade på tannemaljen etter 7 dagers behandling. A toothpaste was prepared which was identical in composition to the toothpaste according to Example I, except that 3.0 parts instead of 1.5 parts disodium dihydrogen ethane-1-hydroxy-1,1-diphosphonate and 30.08 parts in instead of 31.58 parts of water was used. This mixture was also found to be effective and caused no damage to tooth enamel after 7 days of treatment.

Dinatriumdihydrogensaltet av etan-l-hydroksy-1,1-difosfonsyre i forannevnte tannpasta kan erstattes med etan-l-hydroksy-1,1-difosfonsyre eller kalium, ammonium eller substituerte ammonium-salter av disse med i det vesentlige ekvivalente resultater. The disodium dihydrogen salt of ethane-1-hydroxy-1,1-diphosphonic acid in the aforementioned toothpaste can be replaced with ethane-1-hydroxy-1,1-diphosphonic acid or potassium, ammonium or substituted ammonium salts thereof with essentially equivalent results.

EKSEMPEL IIIEXAMPLE III

En annen tannpasta ble fremstilt med folgende sammensetning: Another toothpaste was produced with the following composition:

Når brukt på vanlig måte hemmer denne tannpasta dannelsen av tannsten og ingen avkalkning på tannemaljen ble iakttatt■etter 7 dagers prove. When used in the usual way, this toothpaste inhibits the formation of tartar and no decalcification of the tooth enamel was observed after a 7-day trial.

EKSEMPEL IVEXAMPLE IV

En tannpasta som inneholder 3 deler dinatrium-dihydrogen-etan-1-hydroKsy-l,1-difosfonat og 38,08 deler vann, men ellers identisk med tannpastaen etter eksempel III ble fremstilt. Denne pasta ble funnet å være effektiv og forårsaket ingen iakt-tagbar avkalkning av tannemaljen etter 7 dagers prove. A toothpaste containing 3 parts of disodium dihydrogen-ethane-1-hydroxy-1,1-diphosphonate and 38.08 parts of water, but otherwise identical to the toothpaste according to example III was prepared. This paste was found to be effective and caused no observable decalcification of tooth enamel after 7 days of testing.

Dinatrium-dihydrogensaltet av etan-l-hydroksy-1,1-difosfonsyre som brukes i dette eksempel kan erstattes med dikalium-dihydro-gen-etan-l-hydroksy-1,1-difosfonat, diammonium-dihydrogen-etan-1-hydroksy-l,1-difosfonat eller bis(trietanolammonium)-dihydro-gen-etan-l-hydroksy-1,1-difosfonat med ekvivalente resultater. The disodium dihydrogen salt of ethane-1-hydroxy-1,1-diphosphonic acid used in this example can be replaced by dipotassium dihydrogen-ethane-1-hydroxy-1,1-diphosphonate, diammonium dihydrogen-ethane-1-hydroxy -1,1-diphosphonate or bis(triethanolammonium)-dihydro-gen-ethane-1-hydroxy-1,1-diphosphonate with equivalent results.

Flere munnvannblandinger ble fremstilt i overensstemmelse med nærværende oppfinnelse som folger: Several mouthwash compositions were prepared in accordance with the present invention as follows:

Når brukt på samme måte som konvensonelt munnvann, minst en gang daglig, reduserer hver av ovennevnte munnvann materielt akkumulasjon av kalk på overflaten av tennene. Ingen avkalkning ble observert etter 7 dagers prove på tannemalje ved bruk av disse munnvann. When used in the same manner as conventional mouthwashes, at least once daily, each of the above mouthwashes materially reduces the accumulation of limescale on the surface of the teeth. No decalcification was observed after 7 days of testing on tooth enamel using these mouthwashes.

EKSEMPEL IXEXAMPLE IX

En tyggegummi i overensstemmelse med nærværende oppfinnelse ble sammensatt som folger: A chewing gum in accordance with the present invention was composed as follows:

Denne sammensetning gir et effektivt middel for å hemme tannstendannelse uten å skade tannstrukturen når det tygges regu-lært på vanlig måte. This composition provides an effective means of inhibiting calculus formation without damaging the tooth structure when chewing regularly in the usual way.

EKESMPEL XEXAMPLE X

En profylatisk pasta for bruk av tannlegen for fjerning av flekker og polere tennene etter mekanisk fjerning av tannsten-avsetning sammensettes som folger: A prophylactic paste for use by the dentist to remove stains and polish the teeth after mechanical removal of tartar deposits is composed as follows:

Når påfort på tennene ved hjelp av en profylatisk gummikopp på vanlig måte, hemmer denne pasta at nye tannstensavsetninger utvikler seg. When applied to the teeth using a prophylactic rubber cup in the usual way, this paste inhibits the development of new tartar deposits.

Claims (1)

Tann- eller munnpleiemiddel effektivt for hemning av tannstensdannelse uten skadelig å påvirke tannstrukturen, karakterisert ved at det inneholder fra 0,01 til 10 vekts-% etan-l-hydroksy-1,1-difosfonsyre eller et vannopploselig salt av denne, fortrinnsvis trinatriumsaltet, idet pH for midlet holdes innen området 5 — 11, fortrinnsvis 7 - IO, og eventuelt slipemiddel som er i det vesentlige fritt for vannopploselig kalsium.Dental or oral care agent effective for inhibiting calculus formation without adversely affecting the tooth structure, characterized in that it contains from 0.01 to 10% by weight of ethane-1-hydroxy-1,1-diphosphonic acid or a water-soluble salt thereof, preferably the trisodium salt, the pH of the agent being kept within the range 5 - 11, preferably 7 - 10, and any abrasive which is essentially free of water-soluble calcium.
NO165897A 1965-12-08 1966-12-07 NO124095B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51254865A 1965-12-08 1965-12-08
US73131268A 1968-05-22 1968-05-22

Publications (1)

Publication Number Publication Date
NO124095B true NO124095B (en) 1972-03-06

Family

ID=27057595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO165897A NO124095B (en) 1965-12-08 1966-12-07

Country Status (11)

Country Link
US (1) US3488419A (en)
CH (1) CH490855A (en)
DE (1) DE1617729B2 (en)
DK (1) DK114217B (en)
FI (1) FI48038C (en)
FR (1) FR1514194A (en)
GB (1) GB1110987A (en)
IT (1) IT1008505B (en)
NL (1) NL149701C (en)
NO (1) NO124095B (en)
SE (1) SE324635B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340583A (en) 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678154A (en) * 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3979385A (en) * 1969-11-19 1976-09-07 Henkel & Cie G.M.B.H. 1-Aminoalkane-1,1-diphosphonic acids and their salts
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
DE2104476C2 (en) * 1971-02-01 1983-12-01 Henkel KGaA, 4000 Düsseldorf Process for preventing precipitation in water or aqueous solutions
US3766349A (en) * 1971-11-12 1973-10-16 G Codrino Pushbutton switch, provided with a lighted ideogram
US3934002A (en) * 1972-06-30 1976-01-20 The Procter & Gamble Company Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies
US4025616A (en) * 1973-03-06 1977-05-24 The Procter & Gamble Company Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies
US4083972A (en) * 1973-06-19 1978-04-11 The Procter & Gamble Company Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
DE2456667A1 (en) * 1974-11-30 1976-08-12 Henkel & Cie Gmbh PROCESS FOR STABILIZING CALCIUM HYDROGEN PHOSPHATE ANHYDRIDE AGAINST REALIZATION WITH FLUORION IONS
DE2456787A1 (en) * 1974-11-30 1976-08-12 Henkel & Cie Gmbh PROCEDURE FOR STABILIZING CALCIUM HYDROGEN PHOSPHATE DIHYDRATE AGAINST HYDROLYSIS
DE2456693A1 (en) * 1974-11-30 1976-08-12 Henkel & Cie Gmbh PROCESS FOR STABILIZING CALCIUM HYDROGEN PHOSPHATE ANHYDRIDE AGAINST REALIZATION WITH FLUORIONS
DE2456692A1 (en) * 1974-11-30 1976-08-12 Henkel & Cie Gmbh PROCEDURE FOR STABILIZING CALCIUM HYDROGEN PHOSPHATE DIHYDRATE AGAINST HYDROLYSIS
US4042679A (en) * 1975-11-07 1977-08-16 Colgate-Palmolive Company Antibacterial oral composition
DE3345781A1 (en) * 1983-12-17 1985-06-27 Henkel KGaA, 4000 Düsseldorf ORAL AND DENTAL PRODUCTS
US4569838A (en) * 1983-12-23 1986-02-11 Colgate-Palmolive Company Dentifrice
DE3439094A1 (en) * 1984-10-25 1986-05-07 Henkel KGaA, 4000 Düsseldorf ORAL AND DENTAL PRODUCTS
US4575456A (en) * 1984-11-30 1986-03-11 Colgate-Palmolive Company Gel dentifrice of desirable consistency
DE3607480A1 (en) * 1986-03-07 1987-09-10 Blendax Werke Schneider Co TOOTHPASTE
JPH0753653B2 (en) * 1986-06-11 1995-06-07 而至歯科工業株式会社 Cleaning of removable oral prosthesis and tartar dissolving agent
AT387715B (en) * 1987-05-04 1989-03-10 Blendax Werke Schneider Co TOOTHPASTE
DE3724653A1 (en) * 1987-07-25 1989-02-02 Henkel Kgaa OLEFINIC DIPHOSPHONE ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS THRESHOLDER, AND COMPLEXING COMPOSITIONS CONTAINING OLEFINIC DIPHOSPHONE ACIDS
DE3724654A1 (en) * 1987-07-25 1989-02-02 Henkel Kgaa HYDROXYACETONITRILDIPHOSPHONIC ACID, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE3841775A1 (en) * 1988-12-12 1990-06-13 Henkel Kgaa TOOTHPASTE
US5000940A (en) * 1989-05-30 1991-03-19 Nabisco Brands, Inc. Devices, compositions and the like having or containing an inorganic pyrophosphate
US5094870A (en) * 1989-05-30 1992-03-10 Nabisco Brands, Inc. Canine biscuits containing an inorganic pyrophosphate
US5000973A (en) * 1989-05-30 1991-03-19 Nabisco Brands, Inc. Nutritionally-balanced canine biscuits containing an inorganic pyrophosphate
US5015485A (en) * 1989-05-30 1991-05-14 Nabisco Brands, Inc. Dog biscuits having a coating containing an inorganic pyrophosphate
US5011679A (en) * 1989-05-30 1991-04-30 Nabisco Brands, Inc. Raw hide having a coating containing an inorganic pyrophosphate
US5114704A (en) * 1989-05-30 1992-05-19 Nabisco Brands, Inc. Raw hide having a coating containing an inorganic pyrophosphate
US5000943A (en) * 1989-05-30 1991-03-19 Nabisco Brands, Inc. Canine biscuits containing an inorganic pyrophosphate
US5047231A (en) * 1989-05-30 1991-09-10 Nabisco Brands, Inc. Raw hide containing an inorganic pyrophosphate
DE4007431A1 (en) * 1990-03-09 1991-09-12 Henkel Kgaa ENAMEL PROTECTING ORAL AND DENTAL CARE PRODUCTS
US6214320B1 (en) * 1990-10-09 2001-04-10 Colgate-Palmolive Company Oral compositions containing anticalculus and antiplaque agents
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
US5318772A (en) * 1991-12-10 1994-06-07 The Dow Chemical Company Oral compositions for inhibiting calculus formation
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US6200550B1 (en) 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
CA2376258A1 (en) * 1999-06-02 2000-12-14 The Procter & Gamble Company Oral preparations of etidronate disodium
DE10049735A1 (en) * 2000-09-28 2002-04-18 Jenapharm Gmbh Method for the isolation of pharmaceutically acceptable etidronate disodium
US6988887B2 (en) * 2002-02-18 2006-01-24 3M Innovative Properties Company Orthodontic separators
ES2280136B1 (en) 2006-02-17 2008-08-16 Universitat De Les Illes Balears FIXED AND ZINC FIXED DOSE ASSOCIATION.
DE102011082891A1 (en) 2011-09-16 2013-03-21 Wacker Chemie Ag Preservative containing glycolipids
EP2620137B1 (en) 2012-01-30 2017-11-15 Symrise AG Compositions
US9743685B2 (en) 2012-05-16 2017-08-29 Symrise Ag Mixtures having improved cooling effect
EP2725026B1 (en) 2012-10-29 2017-09-06 Symrise AG Heterocyclic neoflavonoids with taste masking properties
JP2016508122A (en) 2012-12-12 2016-03-17 シムライズ アーゲー Preparation
DE202012013357U1 (en) 2012-12-12 2016-07-29 Symrise Ag preparations
EP2981179B1 (en) 2013-02-27 2020-03-04 Symrise AG Compositions comprising vanillin and vanillyl vanillate
EP2865372B1 (en) 2013-10-22 2020-07-22 Symrise AG Capsules comprising actives
EP2865739B1 (en) 2013-10-28 2018-09-19 Symrise AG Use of lactones
ES2738355T3 (en) 2013-10-31 2020-01-22 Symrise Ag Substance mix
EP2883459B1 (en) 2013-12-16 2018-04-04 Symrise AG Compositions for oral consumption
ES2759797T3 (en) 2014-04-01 2020-05-12 Symrise Ag Mixtures of substances
EP2932956B1 (en) 2014-04-14 2017-12-27 Symrise AG Capsules with high active load
EP2954785B1 (en) 2014-06-13 2018-06-06 Symrise AG New composition for improvement of sweet taste comprising rubusoside or alpha-glycolsylrubusoside
EP2960235B1 (en) 2014-06-25 2018-09-26 Symrise AG Tetrahydrofuran derivatives as fragrances
EP3061500B1 (en) 2015-02-25 2019-07-10 Symrise AG Stable dispersions
EP3093002B1 (en) 2015-05-15 2018-04-25 Symrise AG Liquid cooling compositions
CN108473484B (en) 2015-10-01 2021-06-29 弗门尼舍公司 Compounds useful as TRPM8 modulators
US20190289886A1 (en) 2015-12-01 2019-09-26 Symrise Ag Substance mixtures
WO2017140336A1 (en) 2016-02-15 2017-08-24 Symrise Ag Fragrant mixtures containing esters and ketones
EP3451857B1 (en) 2016-05-05 2021-07-14 Symrise AG Coolant mixtures
CN109310595A (en) 2016-05-14 2019-02-05 西姆莱斯股份公司 Containing menthol flavoring formulation
BR112019012142B1 (en) 2016-12-21 2023-10-17 Symrise Ag FRAGRANCE MIX
CN110167667B (en) 2016-12-22 2022-09-20 科勒纸业公司 Microcapsules
WO2018233841A1 (en) 2017-06-22 2018-12-27 Symrise Ag Taste modulating flavoring substances
WO2020033669A1 (en) 2018-08-10 2020-02-13 Firmenich Incorporated Antagonists of t2r54 and compositions and uses thereof
US20220211598A1 (en) 2019-01-15 2022-07-07 Symrise Ag Diester of plant-based 1,3-propanediol
EP3689324A1 (en) 2019-02-04 2020-08-05 Symrise AG New cooling agents and preparations comprising them
EP3864966A1 (en) 2020-02-12 2021-08-18 Savanna Ingredients GmbH Oral compositions comprising allulose crystals
US20230139835A1 (en) 2020-02-12 2023-05-04 Savanna Ingredients Gmbh Allulose in crystalline form
WO2022105986A1 (en) 2020-11-17 2022-05-27 Symrise Ag Novel cooling agents and preparations containing same
WO2023117119A1 (en) 2021-12-23 2023-06-29 Symrise Ag Active ingredients with sialagogue and tingling/fizzy effect, and preparations containing same
WO2023143741A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191199A (en) * 1937-09-17 1940-02-20 Hall Lab Inc Abrasive detergent composition
BE579012A (en) * 1958-09-06 1900-01-01
US3303139A (en) * 1962-01-27 1967-02-07 Henkel & Cie Gmbh Aminophosphonic acids and their derivatives as complex formers for metal ions
NL132418C (en) * 1962-04-13
US3213030A (en) * 1963-03-18 1965-10-19 Procter & Gamble Cleansing and laundering compositions
DE1302557B (en) * 1963-04-09 1971-08-26
US3297578A (en) * 1963-07-26 1967-01-10 Monsanto Co Bleaching, sterilizing, disinfecting, and deterging compositions
US3400148A (en) * 1965-09-23 1968-09-03 Procter & Gamble Phosphonate compounds
US3400176A (en) * 1965-11-15 1968-09-03 Procter & Gamble Propanepolyphosphonate compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340583A (en) 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions

Also Published As

Publication number Publication date
NL149701C (en) 1981-05-15
SE324635B (en) 1970-06-08
FR1514194A (en) 1968-02-23
DE1617729B2 (en) 1973-09-13
FI48038B (en) 1974-02-28
DE1617729A1 (en) 1971-04-08
DK114217B (en) 1969-06-09
IT1008505B (en) 1976-11-30
CH490855A (en) 1970-05-31
NL6616593A (en) 1967-06-09
FI48038C (en) 1974-06-10
US3488419A (en) 1970-01-06
GB1110987A (en) 1968-04-24
NL149701B (en) 1976-06-15

Similar Documents

Publication Publication Date Title
NO124095B (en)
EP0297212B1 (en) Oral compositions
CA2116225C (en) Anticalculus dentifrices
US3553314A (en) Oral compositions for calculus retardation
US3639569A (en) Oral compositions for calculus retardation
TW201625201A (en) Dentifrice comprising zinc - amino acid complex and phosphates
RU2259193C2 (en) Zinc-containing agent for teeth cleansing with reduced sharpness
US3553315A (en) Oral compositions for calculus retardation
US3737522A (en) Oral compositions for calculus retardation
CA2000773C (en) Dental hygiene composition for reducing periodontal disease
BR112019012472B1 (en) COMPOSITION FOR ORAL HYGIENE COMPRISING ZINC SOURCE, STANOS SOURCE AND FLUORIDE SOURCE
US5456903A (en) Method of making a tartar control baking soda dentifrice
USRE29182E (en) Oral composition for calculus retardation
JPH01207227A (en) Tartar preventing composition
US4143128A (en) Oral compositions for calculus retardation
US4144324A (en) Oral compositions for calculus retardation
NO165897B (en) PROGRAMMABLE CLUTCH CLOCK.
US3535420A (en) Oral compositions for calculus retardation
US3894147A (en) Method and composition for inhibiting calculus
JPH1017447A (en) Antiodontolithic agent and composition for oral cavity
US5032389A (en) Zinc tripolyphosphate compounds as anticalculus and antiplaque agents
CN114867450A (en) Oral care compositions and methods of use
GB1573467A (en) Calculusinhibiting compositions
US4105756A (en) Inhibition of dental calculus
US3584116A (en) Oral compositions for calculus retardation